Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 3
- Intertek Extends Its Electromagnetic Compatibility Testing Capabilities to Cover Electromagnetic Fields
- 2/15/2019 11:50:20 AM
- Intertek, a leading Total Quality Assurance provider to industries worldwide, is pleased to announce it has extended its Electromagnetic Compatibility Testing capabilities to cover Electromagnetic Fields (EMFs) and the measurement and mitigation of these fields.
- New Report Shows Global Shift in Use of Antibiotics in Animals
- 2/15/2019 11:09:56 AM
- The OIE has developed a voluntary data collection system on the use of antimicrobial agents in animals to which any country can contribute. The report presents the overall findings of the third annual data collection, providing a global and regional analysis from 2015 to 2017.
- Sight Diagnostics, Maker of Lab-Grade Point-of-Care Blood Diagnostics System OLO, Raises $27.8M In Series C Strategic Funding to Deliver Medical Results to Patients Within Minutes
- 2/14/2019 1:06:58 PM
- Sight Diagnostics, the company working to provide patients with lab-grade blood testing results in minutes rather than days by combining AI with a revolutionary method to ’digitize’ blood, announces today that it has raised $27.8 million in Series C funding led by Longliv Ventures, a member of the CK Hutchison Group – a multinational conglomerate whose portfolio includes …
- Emory University with Children’s Healthcare of Atlanta and UW Health in Wisconsin Join FARE Clinical Network
- 2/13/2019 1:16:04 PM
- Food Allergy Research & Education (FARE), the largest private funder of food allergy research in the world, announced that Emory University with Children’s Healthcare of Atlanta, and UW Health in Wisconsin are joining the FARE Clinical Network, a food allergy research collaborative comprised of 33 leading research and clinical care facilities across the country.
- Spire is now Spire Health, Announces Focus on Remote Patient Monitoring, Makes Key Healthcare Hires
- 2/13/2019 9:34:10 AM
- Spire, Inc., a leading innovator in actionable respiratory monitoring, announced today that it has rebranded as Spire Health ( www.spirehealth.com ).
- New Data From Surescripts Shows That Patients Are Getting More Affordable Prescriptions Faster and With Less Hassle
- 2/12/2019 3:48:10 PM
- Providers nationwide are increasingly adopting prescription price transparency tools at the point of care to positively impact the quality of U.S. healthcare, according to the new Surescripts 2018 Impact Report: Prescription Price Transparency.
- Sutter Health Teams Up With Ada Health to Improve Patient Care by Delivering On-Demand Healthcare Guidance
- 2/12/2019 1:56:35 PM
- Sutter Health, a leading U.S.-based not-for-profit healthcare network, is teaming up with Ada Health to offer personalized, on-demand health guidance to help patients make informed decisions about next steps for care.
- Sapporo Medical University and Fujitsu in Joint R&D for Diabetes Treatment that Uses AI-based Machine Learning
- 2/12/2019 6:23:22 AM
- Sapporo Medical University, Fujitsu Limited, and Fujitsu Hokuriku Systems Limited today announced that this month they will begin development of an AI machine learning model to optimize prescription of oral hypoglycemic medicines in the treatment of diabetes, as part of joint research on AI use with clinical data.
- Sanofi Appoints Ameet Nathwani Chief Digital Officer
- 2/12/2019 6:07:44 AM
- Sanofi has appointed Ameet Nathwani, M.D. as Chief Digital Officer in addition to his current role of Executive Vice-President, Chief Medical Officer.
- European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
- 2/12/2019 5:42:15 AM
- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) announced that the European Commission (EC) extended the current marketing authorization of ADCETRIS (brentuximab vedotin) to include treatment of adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma in combination with AVD (Adriamycin, vinblastine and dacarbazine).
- Bird Flu Shuffle Probes Viral Compatibility
- 2/12/2019 5:31:33 AM
- When influenza viruses that infect birds and humans meet in the same cell, they can shuffle their genomes and produce new strains that might have pandemic potential.
- New Study Shows HPV Not Likely Transmittable Through the Hand
- 2/11/2019 12:31:02 PM
- Commonly known as HPV, Human papillomavirus is a virus that infects the skin and genital area, in many cases leading to a variety of genital, anal, and oropharyngeal cancers in men and women.
- American Telemedicine Association (ATA) Endorses Peer Review Publications Pushing Tech Envelope
- 2/11/2019 7:00:00 AM
- Partners in Digital Health (PDH) is pleased to announce the endorsement of its peer-review journals, Blockchain in Healthcare Today ( BHTY), and Telehealth and Medicine Today (TMT), by the American Telehealth Association (ATA).
- New Ontario Autism Program Draws Support From Across the Province
- 2/8/2019 12:03:56 PM
- Ontario’s Government for the People announced changes to how we support children with autism. The plan provides expanded choice through childhood budgets, offers flexibility that recognizes each child is unique, and commits to doubling funding for the province’s five diagnostic hubs to help ensure children get a timely diagnosis.
- Screening and Discussion of “Addiction” Documentary February 27
- 2/8/2019 11:40:04 AM
- On Wednesday, February 27, at 7 p.m. the National Archives presents a screening and expert panel discussion of the powerful new PBS NOVA documentary Addiction.
- Anaesthesia and Intensive Care to Be Published by SAGE Publishing in Partnership With the Australian Society of Anaesthetists
- 2/8/2019 11:30:54 AM
- SAGE Publishing will be publishing the journal Anaesthesia and Intensive Care as of January 2019. This is in partnership with the Australian Society of Anesthetists.
- Blockchain in Healthcare Today Publishes Top 10 Blockchain Predictions for Healthcare in 2019
- 2/7/2019 1:00:00 PM
- Partners in Digital Health, is pleased to unveil the 1st Annual BHTY Top 10 Blockchain Predictions for Healthcare 2019. With over 20,000 downloads, 18 citations, and readership in over 65 countries worldwide, Blockchain in Healthcare Today (BHTY) is the preeminent open-access international peer-review journal for strategic thought leaders, new-era practitioners, and future …
- Management Sciences for Health Appoints New Head of Business Development
- 2/6/2019 2:32:00 PM
- Management Sciences for Health (MSH), a leading global health NGO, announced that it has appointed Dana Sandstrom Keating as its new head of Business Development and Partnerships, effective February 1, 2019.
- St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences Launches Master of Science Degree Program
- 2/6/2019 2:25:53 PM
- Two years after launching the St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences, where students can earn Ph.D.s while being mentored by St.
- US FDA Grants Fasenra Orphan Drug Designation for Hypereosinophilic Syndrome
- 2/6/2019 12:33:49 PM
- The US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Fasenra (benralizumab) for the treatment of hypereosinophilic syndrome (HES).
